43
Participants
Start Date
April 17, 2017
Primary Completion Date
December 31, 2023
Study Completion Date
May 14, 2026
Berzosertib
Given IV
Cisplatin
Given IV
Computed Tomography
Undergo CT or PET/CT
Laboratory Biomarker Analysis
Correlative studies
Magnetic Resonance Imaging
Undergo MRI
Positron Emission Tomography
Undergo PET/CT
Radiation Therapy
Undergo radiation therapy
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
University of Maryland/Greenebaum Cancer Center, Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
University of Virginia Cancer Center, Charlottesville
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
University of Kentucky/Markey Cancer Center, Lexington
Ohio State University Comprehensive Cancer Center, Columbus
Case Western Reserve University, Cleveland
Wayne State University/Karmanos Cancer Institute, Detroit
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento
Smilow Cancer Center/Yale-New Haven Hospital, New Haven
Yale University, New Haven
Smilow Cancer Hospital Care Center-Trumbull, Trumbull
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Rutgers Cancer Institute of New Jersey, New Brunswick
National Cancer Institute (NCI)
NIH